Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -13,563,834
- Operating income
- -13,988,505
- Earnings per share
- -10.36
Growth and profitability
- Return on equity
- -243.20
- Return on assets
- -173.59
Balance sheet
- Total assets
- 7,813,567
- Total liabilities
- 2,236,253
- Shareholders' equity
- 5,577,314
- Cash and equivalents
- 5,536,955
- Current ratio
- 2.54
Cash flow and ratios
- Operating cash flow
- -11,385,195
Shareholder returns
- Shares outstanding
- 2,798,241
- Book value per share
- 1.99
Company information
- Headquarters
- Vero Beach, FL
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Processa Pharmaceuticals, Inc. trades on NASDAQ under the ticker symbol PCSA. This page brings together its price chart, company profile, key financial figures and technical indicators.